FR2396550A1 - Procede de preparation d'une solution aqueuse bien toleree contenant des sulfonamides et des agents de potentialisation de ceux-ci, pour administration par voie intraveineuse - Google Patents

Procede de preparation d'une solution aqueuse bien toleree contenant des sulfonamides et des agents de potentialisation de ceux-ci, pour administration par voie intraveineuse

Info

Publication number
FR2396550A1
FR2396550A1 FR7817909A FR7817909A FR2396550A1 FR 2396550 A1 FR2396550 A1 FR 2396550A1 FR 7817909 A FR7817909 A FR 7817909A FR 7817909 A FR7817909 A FR 7817909A FR 2396550 A1 FR2396550 A1 FR 2396550A1
Authority
FR
France
Prior art keywords
aqueous solution
well tolerated
solution containing
potentialization
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7817909A
Other languages
English (en)
Other versions
FR2396550B1 (fr
Inventor
Karl Dr Groke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Patheon Austria GmbH and Co KG
Original Assignee
Chemie Linz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemie Linz AG filed Critical Chemie Linz AG
Publication of FR2396550A1 publication Critical patent/FR2396550A1/fr
Application granted granted Critical
Publication of FR2396550B1 publication Critical patent/FR2396550B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Cette invention concerne la préparation d'une solution aqueuse bien tolérée pour administration par voie intraveineuse contenant un sulfonamide et de la 2,4-diamino-5-(3', 4', 5'-triméthoxybenzyl)-pyrimidine. Suivant l'invention, on dissout la pyrimidine dans une solution aqueuse contenant au moins 5 % en poids d'un sucre à fonction alcool et (ou) de glucose et (ou) de fructose et on utilise comme sulfonamide le 3-méthoxy-4-(4'-aminobenzène-sulfonamido)-1,2,5-thiadiazole, en ajustant la teneur de la solution finale en sucre(s) entre 5 et 40 % en poids et, si nécessaire, entre 6 et 8. Ce procédé permet d'obtenir des solutions à base aqueuse ayant des pH admissibles.
FR7817909A 1977-07-08 1978-06-15 Procede de preparation d'une solution aqueuse bien toleree contenant des sulfonamides et des agents de potentialisation de ceux-ci, pour administration par voie intraveineuse Granted FR2396550A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2731013A DE2731013C2 (de) 1977-07-08 1977-07-08 Verfahren zur Herstellung einer wäßrigen Infusionslösung
AT498477A AT351166B (de) 1977-07-08 1977-07-12 Verfahren zur herstellung einer gut ver- traeglichen, intravenoes zu verabreichenden, waessrigen loesung

Publications (2)

Publication Number Publication Date
FR2396550A1 true FR2396550A1 (fr) 1979-02-02
FR2396550B1 FR2396550B1 (fr) 1980-06-13

Family

ID=25601735

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7817909A Granted FR2396550A1 (fr) 1977-07-08 1978-06-15 Procede de preparation d'une solution aqueuse bien toleree contenant des sulfonamides et des agents de potentialisation de ceux-ci, pour administration par voie intraveineuse

Country Status (16)

Country Link
US (1) US4327084A (fr)
JP (1) JPS5417109A (fr)
AT (1) AT351166B (fr)
BE (1) BE862348A (fr)
CH (1) CH637826A5 (fr)
CS (1) CS208479B2 (fr)
DD (1) DD138506A1 (fr)
DE (1) DE2731013C2 (fr)
DK (1) DK159957C (fr)
FI (1) FI58435C (fr)
FR (1) FR2396550A1 (fr)
GB (1) GB1561562A (fr)
IE (1) IE47876B1 (fr)
LU (1) LU79930A1 (fr)
NL (1) NL179704C (fr)
ZA (1) ZA783677B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0241837A2 (fr) * 1986-04-07 1987-10-21 Bristol-Myers Squibb Company Préparation antiémétique stable à injecter

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH647412A5 (de) * 1980-03-25 1985-01-31 Hoffmann La Roche Pharmazeutische praeparate.
GB8617482D0 (en) * 1986-07-17 1986-08-28 Geistlich Soehne Ag Pharmaceutical composition
DE4331147A1 (de) * 1993-09-14 1995-03-16 Nycomed Arzneimittel Gmbh Intravenös verabreichbare, wäßrige Lösung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH544053A (de) * 1966-05-09 1973-11-15 Hoffmann La Roche Verfahren zur Herstellung von Sulfonamidderivaten
SE322866B (fr) * 1966-12-15 1970-04-20 Astra Ab
US3637640A (en) * 1970-05-04 1972-01-25 Diagnostic Data Inc Orgotein stabilized with saccharide process and products
JPS4911403B1 (fr) * 1970-12-29 1974-03-16
GB1469521A (en) * 1973-01-05 1977-04-06 Wellcome Found Antimicrobial preparations

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NV2030/75 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0241837A2 (fr) * 1986-04-07 1987-10-21 Bristol-Myers Squibb Company Préparation antiémétique stable à injecter
EP0241837A3 (en) * 1986-04-07 1989-05-10 Bristol-Myers Company Stable injectable antiemetic compositions

Also Published As

Publication number Publication date
NL179704C (nl) 1986-11-03
FI58435C (fi) 1981-02-10
CS208479B2 (en) 1981-09-15
DK159957B (da) 1991-01-07
IE47876B1 (en) 1984-07-11
JPS5639285B2 (fr) 1981-09-11
FI58435B (fi) 1980-10-31
DE2731013A1 (de) 1979-01-11
US4327084A (en) 1982-04-27
NL7806664A (nl) 1979-01-10
JPS5417109A (en) 1979-02-08
LU79930A1 (fr) 1978-12-07
DD138506A1 (de) 1979-11-07
BE862348A (fr) 1978-06-27
GB1561562A (en) 1980-02-27
DK159957C (da) 1991-05-27
CH637826A5 (de) 1983-08-31
IE781283L (en) 1979-01-08
DE2731013C2 (de) 1982-07-15
NL179704B (nl) 1986-06-02
ATA498477A (de) 1978-12-15
DK243378A (da) 1979-01-09
FR2396550B1 (fr) 1980-06-13
AT351166B (de) 1979-07-10
FI781858A (fi) 1979-01-09
ZA783677B (en) 1979-07-25

Similar Documents

Publication Publication Date Title
Keys et al. Famine edema and the mechanism of its formation
IE811751L (en) Aqueous formulation
BG102163A (en) Inhibitors of adenosinekinase modified in c-4'position
FR2406999A1 (fr) Stabilisant pour polysaccharides de meningocoques
FR2385395A1 (fr) Composition pour instillations
FR2396550A1 (fr) Procede de preparation d'une solution aqueuse bien toleree contenant des sulfonamides et des agents de potentialisation de ceux-ci, pour administration par voie intraveineuse
CA2040982A1 (fr) Derives n-(3-fluoro-2-phosphonylmethoxypropyle) des bases heterocycliques purine et pyrimidine, methode pour leur production et utilisation comme principes actifs de medicaments
BE903483A (fr) Nouvelles formulations galeniques a base de bromocriptine
ATE82681T1 (de) 2',3'-dideoxy-3'-fluorothymidin und verwandte verbindungen zur behandlung von adenovirusinfektionen.
KR870006901A (ko) 인터로이킨-2 조성물의 제조방법
KR880007059A (ko) 염화리소짐 및 글리치르히진산 디칼륨 함유 수용액 제제
EP0355031A2 (fr) Nucléosides pyrimidiniques substitués, leur procédé de préparation et médicaments les contenant
HUT56352A (en) Process for producing imidazole guanidine derivatives and pharmaceutical compositions comprising same as active ingredient
DE60106953D1 (de) Adenosinderivate und deren verwendung
FR2361401A1 (fr) Procede de preparation d'amoxycilline sodique
IE880139L (en) PIPERAZINYLPYRIMIDINES AS ß-ADRENERGIC RECEPTOR BLOCKERS
KR970005016A (ko) 2'-데옥시-2 -메틸리덴시티딘 이수화물 함유 조성물
US4133879A (en) Process for producing stable solutions of a sulphonamide and a potentiator
FR2405970A1 (fr) Resine cellulaire d'uree-formaldehyde, et procede de preparation
EP0667159B1 (fr) Ampule contenant une solution injectable concentrée de sels de métaux alcalins de falates réduits
FR2408347A1 (fr) Solution pour infusion pour le traitement de l'encephalopathie hepatique et procede pour sa preparation
ATE64740T1 (de) Platin enthaltender cytostatischer wirkstoff.
US5554618A (en) Intravenously administrable aqueous solution
KR910007522A (ko) 수용성 펜타미딘 염의 안정화된 수성용액
US2738300A (en) Stable aqueous penicillin preparation

Legal Events

Date Code Title Description
TP Transmission of property